Indeed, a certain increase in CIN can enhance tumor heterogeneity and fitness, and correlates with poor prognosis.[7] Our current findings show that YY2 could promote transcription of BUB1B, which is involved in assuring proper mitotic checkpoint activity and chromosome segregation. The gene discussed is YY2; the disease is neoplasm.